Literature DB >> 33804441

Structure of the Signal Transduction Domain in Second-Generation CAR Regulates the Input Efficiency of CAR Signals.

Kento Fujiwara1, Masaki Kitaura1, Ayaka Tsunei1, Hotaka Kusabuka1, Erika Ogaki1, Naoki Okada1.   

Abstract

T cells that are genetically engineered to express chimeric antigen receptor (CAR) have a strong potential to eliminate tumor cells, yet the CAR-T cells may also induce severe side effects due to an excessive immune response. Although optimization of the CAR structure is expected to improve the efficacy and toxicity of CAR-T cells, the relationship between CAR structure and CAR-T cell functions remains unclear. Here, we constructed second-generation CARs incorporating a signal transduction domain (STD) derived from CD3ζ and a 2nd STD derived from CD28, CD278, CD27, CD134, or CD137, and investigated the impact of the STD structure and signaling on CAR-T cell functions. Cytokine secretion of CAR-T cells was enhanced by 2nd STD signaling. T cells expressing CAR with CD278-STD or CD137-STD proliferated in an antigen-independent manner by their STD tonic signaling. CAR-T cells incorporating CD28-STD or CD278-STD between TMD and CD3ζ-STD showed higher cytotoxicity than first-generation CAR or second-generation CARs with other 2nd STDs. The potent cytotoxicity of these CAR-T cells was not affected by inhibiting the 2nd STD signals, but was eliminated by placing the STDs after the CD3ζ-STD. Our data highlighted that CAR activity was affected by STD structure as well as by 2nd STD signaling.

Entities:  

Keywords:  CAR structure-activity relationship; chimeric antigen receptor; signal transduction domain

Mesh:

Substances:

Year:  2021        PMID: 33804441      PMCID: PMC7957710          DOI: 10.3390/ijms22052476

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  42 in total

1.  Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product.

Authors:  H M Finney; A D Lawson; C R Bebbington; A N Weir
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

Review 2.  Cell Biology of T Cell Receptor Expression and Regulation.

Authors:  Andrés Alcover; Balbino Alarcón; Vincenzo Di Bartolo
Journal:  Annu Rev Immunol       Date:  2017-12-20       Impact factor: 28.527

3.  Analysis of CAR-Mediated Tonic Signaling.

Authors:  Hugo Calderon; Maksim Mamonkin; Sonia Guedan
Journal:  Methods Mol Biol       Date:  2020

Review 4.  Helix formation and stability in membranes.

Authors:  Matthew J McKay; Fahmida Afrose; Roger E Koeppe; Denise V Greathouse
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-02-13       Impact factor: 3.747

5.  Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.

Authors:  Carmine Carpenito; Michael C Milone; Raffit Hassan; Jacqueline C Simonet; Mehdi Lakhal; Megan M Suhoski; Angel Varela-Rohena; Kathleen M Haines; Daniel F Heitjan; Steven M Albelda; Richard G Carroll; James L Riley; Ira Pastan; Carl H June
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

6.  Current concepts in the diagnosis and management of cytokine release syndrome.

Authors:  Daniel W Lee; Rebecca Gardner; David L Porter; Chrystal U Louis; Nabil Ahmed; Michael Jensen; Stephan A Grupp; Crystal L Mackall
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

7.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

Review 8.  Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations.

Authors:  Robert Weinkove; Philip George; Nathaniel Dasyam; Alexander D McLellan
Journal:  Clin Transl Immunology       Date:  2019-05-11

9.  Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma.

Authors:  Zhitao Ying; Ting He; Xiaopei Wang; Wen Zheng; Ningjing Lin; Meifeng Tu; Yan Xie; Lingyan Ping; Chen Zhang; Weiping Liu; Lijuan Deng; Feifei Qi; Yanping Ding; Xin-An Lu; Yuqin Song; Jun Zhu
Journal:  Mol Ther Oncolytics       Date:  2019-08-28       Impact factor: 7.200

10.  Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold.

Authors:  Kento Fujiwara; Ayaka Tsunei; Hotaka Kusabuka; Erika Ogaki; Masashi Tachibana; Naoki Okada
Journal:  Cells       Date:  2020-05-09       Impact factor: 6.600

View more
  3 in total

1.  A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine.

Authors:  Mahdi Abdoli Shadbad; Nima Hemmat; Vahid Khaze Shahgoli; Afshin Derakhshani; Farzad Baradaran; Oronzo Brunetti; Rossella Fasano; Renato Bernardini; Nicola Silvestris; Behzad Baradaran
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

2.  The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity.

Authors:  Sachiko Hirobe; Keisuke Imaeda; Masashi Tachibana; Naoki Okada
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

Review 3.  Emerging Trends in Immunotherapy for Cancer.

Authors:  Alok K Mishra; Amjad Ali; Shubham Dutta; Shahid Banday; Sunil K Malonia
Journal:  Diseases       Date:  2022-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.